2022 FALL HYBRID GROUP MEETING
November 2-5
Join us as we continue to celebrate our 10-year anniversary at the 2022 Alliance Fall Hybrid Group Meeting November 2-5.
The four-day meeting will host a variety of scientific and administrative sessions led by distinguished oncology researchers, clinical trial specialists, and administrators from across the country. It will showcase novel and innovative cancer control, prevention, and treatment trials conducted by investigators through a multidisciplinary academic and community research network, as part of the NCI National Clinical Trials Network (NCTN) and Community Oncology Research Program (NCORP).
All attendees must register in advance to attend the meeting and to gain virtual access to each Group meeting session. As a reminder, registrants must log in to the meeting website/app using the same credentials used to register to access and browse open sessions, view agendas and presentations, connect with other attendees, and more. Note: Closed sessions are by invitation only and information will not be visible on the website/app. For meeting and registration questions, please e-mail AllianceTravel@bwh.harvard.edu.
View the meeting schedule.
Meeting presentations can be found on the Alliance member site in the coming week.
Below are a few meeting highlights.
All times noted are Central Standard Time (CST).
PLENARY SESSION :: Friday, November 4, 10 am-1 pm
Welcome and Announcements
Suzanne George, MD
Interim Group Chair
Alliance for Clinical Trials in Oncology
Olwen Hahn, MD
Director and Principal Invesitgator
Alliance Central Protocol Operations Program
Guest Lecturers
W. Fraser Symmans, MB.ChB.
Chair, Alliance Translational Research Program
Professor and Director of Research Operationbs, Department of Pathology
Professor of Translational Molecular Pathology
University of Texas MD Anderson Cancer Center
Evanthia Galanis, MD
Chair, Alliance Neuro-Oncology Committee
Professor of Oncology and Sandra J. Shulze Professor of Novel Therapeutics
Mayo Clinic Operations Program
Annual Awards
20
22 Richard L. Schilsky Cancer and Leukemia Group B Achievement Award
Gini F. Fleming, MD
Professor of Medicine and Director
Gynecologic Oncology and Medical Oncology Breast Cancer Program
University of Chicago Medicine
The RLS CALGB Achievement Award was established in 2010 to recognize the 15-year tenure of Dr. Schilsky as Group Chair of Cancer and Leukemia Group B (CALGB). The award acknowledges the significant contributions of an individual to cooperative group research. An expert in breast and gynecological cancers, Gini F. Fleming, MD, is this year's award recipient. Dr. Fleming is a Professor of Medicine and Director of Gynecologic Oncology and Medical Oncology Breast Cancer Program at the University of Chicago Medicine. Her recent research examines novel therapeutics in breast, ovarian and endometrial cancers. She has led numerous phase III trials in endometrial cancer which led to the introduction of paclitaxel as standard therapy for the disease, and served as North American Co-Chair of an international breast cancer trial (Suppression of ovarian function trial - SOFT) that led to practice-changing results regarding the benefit of ovarian function suppression in the adjuvant therapy premenopausal women with breast cancer. She has authored and co-authored more than 100 articles for a variety of medical journals, in addition to a number of textbook chapters. In addition, Dr. Fleming has served as Director and Principal Investigator of the Alliance Central Protocol Operations Program and Chief Scientific Officer for Alliance Foundation Trials, LLC.
**********
21st ANNUAL JIMMIE HOLLAND LECTURE :: Saturday, November 5 | 10 am-11 am
“Sexuality, Cancer, and the Human Experience: Acknowledgment to Recovery”
Don S. Dizon, MD, FACP, FASCO
Director, Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics, Lifespan Cancer Institute
Director of Medical Oncology, Rhode Island Hospital
Founder, Oncology Sexual Health First Responders Program
Sponsored by the Alliance Health Outcomes Committee, the Jimmie Holland Lecture was established to honor Dr. Holland’s contributions to the field of psycho-oncology in the CALGB/Alliance. Those receiving this honor have demonstrated notable contributions in psycho-oncology, contributing to Dr. Holland’s legacy. Don S. Dizon, MD, FACP, FASCO, is the recipient of this year’s award. Dr. Dizon is a Professor of Medicine at Brown University, Director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and Director of Medical Oncology and the Oncology Sexual Health First Responders Clinic at Rhode Island Hospital. As a medical oncologist, he specializes in the care of women's cancers and the sexual health of cancer survivors, and is an expert in psycho-oncology. In addition to his clinical duties, Dr. Dizon co-chairs the Cervical Cancer Task Force for the NCI Gynecologic Cancer Steering Committee. He is also prolific on social media and maintains online columns for ASCO and for the journal, The Oncologist. In 2017, he collaborated with colleagues across the United States and founded the Collaboration for Outcomes using Social Media in Oncology.
**********
CLINICAL RESEARCH PROFESSIONALS SESSIONS
The Clinical Research Professionals (CRP) Orientation (Wednesday, November 2 | 1 pm-3 pm) is targeted to CRPs, including data managers, clinical research coordinators, regulatory coordinators, and research nurses, within their first 18 months of oncology research or their first 18 months of affiliation with Alliance trials. This session provides an opportunity to learn about the Alliance organizational structure, the Alliance protocol template, eligibility check best practices, and CRP resources on the Alliance website. Alliance CRP Breakout Sessions complement the information provided in the orientation session.
:: CRP Breakout: Data Management Tips to Avoid Common Errors (Wednesday, November 2 | 3:30 pm-4:30 pm)
Presented by Alliance Statistics and Data Management Center (SDMC), this session is designed for CRPs completing Rave data for any study and will focus on data completion, tips for avoiding common data errors including AE reporting and baseline data tips.
:: CRP Breakout: BioMS & Specimen Collection DOs and DON’Ts (Wednesday, November 2 | 5 pm-6:30 pm)
Learn about BioMS Sample submission entries from Amy Brink, Clinical Informaticist from the BioMS Application Support Team, and Chris Manring, MBA, LSSGB, Assistant Director of the Leukemia Tissue Band and Alliance HEBE Biorepository. Through a lively presentation, presenters will walk through tips to avoid common pitfalls when entering samples in BioMS, and will review common specimen collection, shipment and packaging errors to avoid.
The CRP Information Session (Thursday, November 3 | 12:30 pm-3 pm) will provide information to CRPs, including clinical research coordinators, data managers, regulatory coordinators, and research nurses, about Alliance updates and resources. Presentations will include:
- Results from the COVID-19 Database Data Collection
- Aurora, NCI’s new electronic and centralized agent inventory management system present by CTEP’s Pharmaceutical Management Branch
- Alliance Protocol Office Updates from Trini Ajazi, MM, Alliance Chief Operating Officer
- Alliance A032101 (prostate cancer trial) presented by Study Chair Atish Choudhury, MD, PhD
- CTSU Updates including details about ID.me and troubleshooting tips on the required identity proofing and multifactor authentication application
- Alliance Statistics and Data Management Center Update from Jenny Darcy, Director, Alliance SDMC Data Coordination Unit
The CRP Education Session (Friday, November 4 | 8 am-10 am) will include overviews of Alliance A121202 (MCED Biobank Study) by Study Chair Marie Wood, MD; Alliance A091903 (Resected Mucosal Melanoma Study) by Study Chair Alexander Shoushtari, MD; and Alliance A022001 (Pancreatic Neuroendocrine Tumors Study) by Study Chair Timothy Hobday, MD, along with a presentation on Clinical Research Professionals (CRP) Attitudes towards ePRO by Youmin Cho, MSN, RN, AGPCNP-BC, PhD Candidate.
:: CRP Breakout: Onboarding New Staff (Friday, November 4 | 1 pm-2 pm)
This session will discuss strategies to onboard new staff presented by Betsy Barnick, MHS, CCRP; Terah Hardcastle, MS; and Katie Lemos, MPH. Discussion will focus on successful onboarding processes and strategies, available resources, and a checklistsfor onboarding new CRPs.
:: CRP Breakout: SAE Integration: Tips for Reporting SAEs through RAVE (Friday, November 4 | 2:30 pm -3:30 pm)
Kristina Lauman will walk through successful processes and helpful tips for reporting SAEs through RAVE.
:: CRP Breakout: Regulatory Overview (Friday, November 4 | 4 pm-5 pm)
This session will offer background into the purpose and goals of regulatory regulations. Erin Lynch, MS, CCRP and Jamie Crow, MS, MBA, MHA, CCRP will explain how regulatory affairs the backbone of research and why regulatory affairs is critical to research operations.
:: CRP Breakout: Power Round! Highlighting Tools for Onboarding New Staff and Strategies of Strong Research Programs (Friday, November 4 | 5:30 pm-6:30 pm)
This interactive, discussion-based session will not be a repeat of the 1 pm session. This session will provide additional resources for onboarding new staff and creating and maintaining a strong research program and will also dig deeper into various processes of managing clinical trials.
**********
ONCOLOGY NURSING + CLINICAL RESEARCH PROFESSIONALS
Oncology Nursing Education Session :: Thursday, November 3 | 9 am-11 am
This interactive session will feature three talks on antibody-drug conjugates (ADC - considered one of the fastest growing anticancer drugs), and the upcoming NCI MyeloMATCH and Optum-ICE trials. In addition, Alliance Oncology Nursing Research Education Taskforce members will discuss updates on upcoming research educational training activities.
Oncology Nursing/CRP Open Forum :: Thursday, November 3 | 11 am-12 pm
Calling all CRPs and Research Nurses to attend this open forum to discuss changes in oncology research, challenges. This is an opportunity to find out how other sites are addressing challenges and to share with how your site is handling recent changes in oncology research.
**********
AUDIT WORKSHOP :: Thursday, November 3 | 5:30 pm-8:30 pm
Alliance Audit Committee Chair Scott Okuno, MD, and Audit Program Director Kurombi Wade-Oliver, CCRP, will present an overview of audit resources and the Alliance audit program. Discussion topics will include the PI perspective on participating in audits, regulatory requirements for audits and drug accountability, how to prepare for an audit, how to appropriately tag medical records, evaluate the results from an audit report, and write a corrective action plan.
**********
ALLIANCE FOUNDATION TRIALS (AFT) SESSIONS
Thursday, November 3
9 am-10 am :: AFT-25 COMET
11 am-12 pm :: AFT-38 PATINA
11:30 am-12:30 pm :: AFT-50 EndoMAP
12 pm-1 pm :: AFT-58 HARMONIA
3 pm-4 pm :: AFT-19 and AFT-4
3 pm-4:30 pm :: Alliance Foundation Trials (AFT) Overview and Updates*
Friday, November 4
1 pm-2 pm :: AFT Myeloma and Lymphoma Studies
2 pm-3 pm :: AFT-63 and AFT-64: DELFI-L101 and DELFI-L20
(Sessions are closed to Alliance members only; except where * noted)
**********
CONTINUING EDUCATION CREDITS
RN, OCN, ARNP - ONA Credit - The Ohio Nurses Association (ONA) is the largest approver unit of CE credit in the country, accredited by the American Nurses Credentialing Center's Commission on Accreditation. To receive ONA credit, attendees must complete a required survey e-mailed to them after the meeting.
CCRP - SoCRA Credit - The Society of Clinical Research Associates (SoCRA) provides training, continuing education, and an internationally recognized certification program that promotes quality clinical research to protect the welfare of research participants and improve global health. To receive SoCRA credit, attendees must complete a required survey e-mailed to them after the meeting.
For more information about continuing education credits, contact Matt Corso (Alliance Training and Adminsitrative Program Specialist) at mcorso@alliancenctn.org
**********
Join the Conversation :: ALLIANCE ON SOCIAL MEDIA
Share your meeting experience and session highlights using the hashtag - #AllianceFall2022. Find and follow us on Twitter: @ALLIANCE_org and on Facebook at https://www.facebook.com/AllianceForClinicalTrialsInOncology/
* * * * * * * * * * * * * * * * * * * * * *
2022 SPRING HYBRID GROUP MEETING
May 11-14
Join us as we celebrate our 10-year anniversary in Chicago this May. It’s been two years since our last face-to-face Group meeting, and we look forward to connecting with you at the 2022 Alliance Spring Hybrid Group Meeting. We will be reviewing our accomplishments over the past 10 years, and, as always, engaging the entire Alliance community in planning for the future. This will be our first hybrid meeting where members can attend either in-person or online, so we hope that everyone will participate.
Visit Cvent to manage your registration.
To view the meeting schedule, click here.
Remember: sessions listed as closed are only open to official committee members and invited guests. Registration must be completed to gain access to the Zoom information on the meeting website. For questions about the Group meeting, please contact AllianceTravel@bwh.harvard.edu.
One more ask: If you have photos of Alliance members engaging in Alliance-related activities (at Group meetings, at sites/institutions, etc.) from 2011 to present, share them with us by March 25. These photos will be included in a special meeting book and in other anniversary presentations. Send photos, including brief descriptive captions, to Alliance10Year@AllianceNCTN.org.
Social Media Hashtag: #AllianceSpring2022
Online Meeting Sessions
To gain access to each Group meeting session, attendees must register in advance. To access the web links for open sessions, registrants must log in to either the meeting website or the phone/tablet mobile meeting app using the same credentials used to register. Weblinks only will be available on the meeting website and app. The website and app can also be used to browse sessions, view agendas and presentations, connect with other attendees, and more. Note: Closed sessions are by invitation only and information is not visible on the website or app.
* * * * * * * * * * * * * * * * * * * * * *
2021 FALL VIRTUAL GROUP MEETING
PRESENTATIONS & MATERIALS | November 3-6
All meeting sessions and committee meetings will be held virtually for this Group meeting. To gain access to each Group meeting session, attendees must register in advance. To access the web links for open sessions, registrants must log in to either the meeting website or the phone/tablet mobile meeting app using the same credentials used to register. Weblinks only will be available on the meeting website and app. The website and app can also be used to browse sessions, view agendas and presentations, connect with other attendees, and more. Note: Closed sessions are by invitation only and information is not visible on the website or app. For meeting and registration questions, please e-mail AllianceTravel@bwh.harvard.edu.
MEETING SCHEDULE
Social Media Hashtag: #AllianceFall2021
* * * * * * * * * * * * * * * * * * * * * *
2021 SPRING VIRTUAL GROUP MEETING
PRESENTATIONS & MATERIALS | May 12-15
* * * * * * * * * * * * * * * * * * * * * *
How to access the 2021 Alliance Spring Virtual Meeting
All meeting sessions and committee meetings will be held virtually for this Group meeting. To gain access to each Group meeting session, attendees must register in advance. Meeting registrants will receive an e-mail with instructions on how to download the Group meeting app. To access the web links for open sessions, registrants must log in to either the meeting website or the phone/tablet mobile meeting app using the same credentials used to register. The web links will not be sent via e-mail or posted to the Alliance website. The website and app can also be used to browse sessions, view agendas and presentations, connect with other attendees, and more. Note: Closed sessions are by invitation only and information is not visible on the website or app. All questions about the meeting and registration should be addressed to AllianceTravel@bwh.harvard.edu.
MEETING SCHEDULE
Social Media Hashtag: #AllianceSpring2021
Helpful ZOOM Guides & Tools
-
Using Audio/Video Conferencing
Here's a Zoom Cheat Sheet for Meeting Attendees and Zoom/Alliance User Guide -
Zoom Backgrounds
Download free virtual backgrounds for each Alliance entity to display during a Zoom meeting.
Click here for instructions on how to add these custom images as Zoom backgrounds.
Click HERE to view options and click BELOW to download and save the desired background.
There are several different backgrounds available for each Alliance entity.
2020 FALL VIRTUAL GROUP MEETING
PRESENTATIONS & MATERIALS | November 4-7
All meeting sessions and committee meetings will be held virtually for this Group meeting. To gain access to each Group meeting session, attendees must register in advance. Meeting registrants will receive an e-mail with instructions on how to download the Group meeting app. To access the web links for open sessions, registrants must log in to either the meeting website or the phone/tablet mobile meeting app using the same credentials used to register. The web links will not be sent via e-mail or posted to the Alliance website. The website and app can also be used to browse sessions, view agendas and presentations, connect with other attendees, and more. Note: Closed sessions are by invitation only and information is not visible on the website or app. All questions about the meeting and registration should be addressed to AllianceTravel@bwh.harvard.edu.
MEETING SCHEDULE
SOCIAL MEDIA HASHTAG: #AllianceFall2020
Helpful Zoom Guides & Tools
-
Using Audio/Video Conferencing
Here's a Zoom Cheat Sheet for Meeting Attendees and Zoom/Alliance User Guide -
Zoom Backgrounds
Download free virtual backgrounds for each Alliance entity to display during a Zoom meeting.
Click here for instructions on how to add these custom images as Zoom backgrounds.
Click HERE to view options and click BELOW to download and save the desired background.
There are several different backgrounds available for each Alliance entity.
2020 SPRING VIRTUAL GROUP MEETING
PRESENTATIONS & MATERIALS | May 14-16
For this Group meeting, Alliance meeting sessions and committee meetings will be held virtually. For sessions that are open to all Alliance members, weblinks and dial-in information are posted on the Alliance member website. For closed meetings, weblinks and dial-in information will be sent to each specific committee rather than posting these details online. If you have questions, please contact Christina Patel, Alliance Meetings and Events Coordinator, by e-mail capatel@bwh.harvard.edu or phone (617) 525-6543.
Please continue to watch and check this site for meeting and schedule updates.
Also, note that agendas for some meetings/sessions will not be posted.
WELCOME MESSAGE FROM GROUP CHAIR - MONICA M. BERTAGNOLLI, MD (video)
PRINTABLE MEETING SCHEDULE
REGISTER
SOCIAL MEDIA HASHTAG: #AllianceSpring2020
Helpful Guides & Tools | Using Audio/Video Conferencing
Zoom Cheat Sheet - Attendee
AGENDAS
ICARE Working Group/General Info Session | Agenda
TRP Pharmacogenomics and Population Pharmacology Committee | Agenda
Respiratory Committee | Agenda
CRP Information Session | Agenda
Community Oncology Committee | Agenda
Immuno-Oncology Committee | Agenda
Patient Advocate Committee | Agenda
Symptom Intervention Committee | Agenda
CRP Education Session | Agenda
Breast Local Regional Group | Agenda
Health Disparities Committee / Adolescent Young Adult Working Group | Agenda
Cancer in the Older Adult Committee | Agenda
Prevention Committee | Agenda
Myeloma Committee | Agenda
2019 FALL GROUP MEETING PRESENTATIONS & MATERIALS / Nov 7-9
SCHEDULE: Day-to-Day Guide
AGENDAS: Sessions and Committee Meetings
Note: Agendas for some sessions will not be posted.
- ACS CRP- Cancer Care Delivery Research
- ACS CRP- Dissemination and Implementation
- ACS CRP- Education Committee
- Breast Committee
- Cancer in the Older Adult Committee
- Community Oncology Committee
- CRP Education
- CRP Information
- CRP/Oncology Nursing Open Forum
- CRP Orientation Refresher
- GI Committee
- Health Disparities Committee
- Health Outcomes Committee
- Immuno-Oncology Committee
- Multiple Myeloma Committee
- Patient Advocate Committee
- Pharmacogenomics and Population Pharmacology Committee
- Radiation Oncology Committee
- Respiratory Committee
ePOSTERS
Active Alliance and AFT Trials
- Alliance A011104/ACRIN 6694: Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
- Alliance A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
- Alliance A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Her2 Negative Breast Cancer: The ABC Trial
- Alliance A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)
- Alliance A021602: Randomized, Double-blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors After Progression on Everolimus
- Alliance A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed By High-dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment Of Germ Cell Tumors (TIGER)
- Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) vs Observation
-
Alliance A031701: A Phase II Study of Dose-dense Gemcitabine Plus Cisplatin (ddGC) in Patients with Muscle-invasive Bladder Cancer with
Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations - Alliance A031702: A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
- Alliance A031704: PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
- Alliance A041501: A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL
- Alliance A041701: A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
- Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
- Alliance A041703: A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Phnegative CD22-positive B-lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease
- Alliance A071601: Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
- Alliance A071701: Genomically-Guided Treatment Trial in Brain Metastases
- Alliance A081105: Randomized Double Blind Observation Controlled Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
- Alliance A091605: A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma
- Alliance A091802: Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)
- Alliance A151216: Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
- Alliance A171601: A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-positive, HER2-Negative Metastatic Breast Cancer
- Alliance A211102: Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention versus Placebo Control in Premenopausal Women
- Alliance A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
- Alliance A211601: Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion Study to Alliance Study A011502
- Alliance A211701: A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort
- POSITIVE (IBCSG 48-14/BIG 8-13/A221405): A Study Evaluating Pregnancy and Disease Outcome and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer Who Desire Pregnancy
- Alliance A221504: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
- Alliance A221505: RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction
- Alliance 221602: Olanzapine with or without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo Controlled Trial
- Alliance A221701: Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches
- Alliance A221702: ARM: Axillary Reverse Mapping - A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence after Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection with and without Axillary Reverse Mapping
- Alliance A231601CD: Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
- Alliance A231701CD: Increasing Socioeconomically Disadvantaged Patients' Engagement in Breast Cancer Surgery Decision Making Through a Shared Decision Making Intervention (A Limited Access Study)
- CALGB (Alliance) 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
- Alliance N0577 (CODEL): Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma (CODEL)
- AFT-05: PALLAS: PALbociclib CoLlaborative Adjuvant Study - A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
- AFT-09: Randomized Phase II Trial Evaluating the Optimal Sequencing of PD-1 Inhibition with Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in Patients with Chemotherapy Naive Stage IV Non-small Cell Lung Cancer
- AFT-15: A Phase I Study of Ibrutinib (PCI-32765) in Combination with Revlimid/dexamethasone (Rd) in Relapsed/Refractory Multiple Myeloma
- AFT-16: Phase II Trial of Induction Immunotherapy with Atezolizumab for Patients with Unresectable Stage IIIA and IIIB NSCLC Eligible for Chemoradiotherapy with Curative Intent
- AFT 19: A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
- COMET Study (AFT-25): Comparison of Operative to Monitoring and Endocrine Therapy for Low-risk DCIS
- CANVAS Trial (AFT-28): DOACS versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial
- AFT-32: A Phase II Study of Palbociclib (PD-0322991) in Combination with Ibrutinib in Patients with Previously Treated Mantle Cell Lymphoma
- AFT-38: A Randomized, Open-Label, Phase 3 Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy Versus Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
- PRO-TECT Study (AFT-39): Electronic Patient Reporting of Symptoms During Cancer Treatment
- AFT-42: Safety, Activity, and Pharmacology of Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
2019 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 8-11
SCHEDULE: Day-to-Day Guide
AGENDAS: Sessions and Committee Meetings
Note: Agendas for some sessions will not be posted.
- ACS CRP- Cancer Care Delivery Research
- ACS CRP- Cancer Care Standards Development
- ACS CRP- Dissemination and Implementation
- ACS CRP- Education Committee
- Cancer in the Older Adult Committee
- Community Oncology Committee
- CRP Education
- CRP Information
- CRP Orientation
- Genitourinary Committee
- GI Committee
- Health Disparities Committee
- Health Outcomes Committee
- Immuno-Oncology Committee
- Leukemia Committee
- Lymphoma Committee
- Multiple Myeloma Committee
- Neuro-Oncology Committee
- Patient Advocates Committee
- Radiation Oncology Committee
- Respiratory Committee
AGENDAS: Alliance Foundation Trials (AFT)
Note: Agendas for some sessions will not be posted.
PRESENTATIONS: Sessions and Workshops
Note: Presentations for some sessions/workshops will not be posted.
ePOSTERS
Active Alliance and AFT Trials
- Alliance A011104/ACRIN 6694: Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
- Alliance A011106: Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
- Alliance A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Receiving Neoadjuvant Chemotherapy
- Alliance A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
- Alliance A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Her2 Negative Breast Cancer: The ABC Trial
- Alliance A021501: Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
- Alliance A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)
- Alliance A021602: Randomized, Double-blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors After Progression on Everolimus
- Alliance A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed By High-dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment Of Germ Cell Tumors (TIGER)
- Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) vs Observation
-
Alliance A031701: A Phase II Study of Dose-dense Gemcitabine Plus Cisplatin (ddGC) in Patients with Muscle-invasive Bladder Cancer with
Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations - Alliance A041501: A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL
- Alliance A041701: A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
- Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
- Alliance A041703: A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Phnegative CD22-positive B-lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease
- Alliance A061402: Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy
- Alliance A071601: Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
- Alliance A081105: Randomized Double Blind Observation Controlled Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
- Alliance A091302: Randomized Phase II Study of Sorafenib with or without Everolimus in Patients with Radioactive Iodine Refractory Hürthle Cell Thyroid Cancer
- Alliance A091605: A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell Carcinoma
- Adjuvant Targeted Therapy Following Standard Adjuvant Therapy for Resected NSCLC: An Initial Report from ALCHEMIST (Alliance A151216)
- Alliance A171601: A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-positive, HER2-Negative Metastatic Breast Cancer
- Alliance A171603: Feasibility of an Electronic Geriatric Assessment (eGA) for Older Adults with Cancer (A Limited Access Study)
- Alliance A191402CD: Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men (A Limited Access Study)
- Alliance A211102: Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology After 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention versus Placebo Control in Premenopausal Women
- Alliance A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
- Alliance A211601: Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion Study to Alliance Study A011502
- Alliance A211701: A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort
- POSITIVE (IBCSG 48-14/BIG 8-13/A221405): A Study Evaluating Pregnancy and Disease Outcome and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer Who Desire Pregnancy
- Alliance A221504: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
- Alliance A221505: RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction
- Alliance 221602: Olanzapine with or without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo Controlled Trial
- Alliance A221701: Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches
- Alliance A231701CD: Increasing Socioeconomically Disadvantaged Patients' Engagement in Breast Cancer Surgery Decision Making Through a Shared Decision Making Intervention (A Limited Access Study)
- CALGB (Alliance) 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
- N0392 (Alliance): Assessment of Patient Satisfaction with Participation in Phase II/III NCCTG Clinical Trials
- Alliance N0577 (CODEL): Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma (CODEL)
- 2019 Alliance Patient Advocate Committee: Adding Value to the Alliance Clinical Trial Process
- AFT-05: PALLAS: PALbociclib CoLlaborative Adjuvant Study - A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
- AFT-07 (M14-360): A Phase 1 Dose Escalation and Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Tolerability of Veliparib in Combination with Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Subjects with Stage III Non-Small Cell Lung Cancer (NSCLC)
- AFT-09: Randomized Phase II Trial Evaluating the Optimal Sequencing of PD-1 Inhibition with Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in Patients with Chemotherapy Naive Stage IV Non-small Cell Lung Cancer
- AFT-15: A Phase I Study of Ibrutinib (PCI-32765) in Combination with Revlimid/dexamethasone (Rd) in Relapsed/Refractory Multiple Myeloma
- AFT-16: Phase II Trial of Induction Immunotherapy with Atezolizumab for Patients with Unresectable Stage IIIA and IIIB NSCLC Eligible for Chemoradiotherapy with Curative Intent
- AFT 19: A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
- COMET Study (AFT-25): Comparison of Operative to Monitoring and Endocrine Therapy for Low-risk DCIS
- CANVAS Trial (AFT-28): DOACS versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial
- AFT-32: A Phase II Study of Palbociclib (PD-0322991) in Combination with Ibrutinib in Patients with Previously Treated Mantle Cell Lymphoma
- AFT-38: A Randomized, Open-Label, Phase 3 Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy Versus Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
- PRO-TECT Study (AFT-39): Electronic Patient Reporting of Symptoms During Cancer Treatment
- AFT-42: Safety, Activity, and Pharmacology of Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
* * * * * * * * * *
2018 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 1-3
SCHEDULE: Day-to-Day Guide
New Alliance Meeting App Instructions
AGENDAS: Sessions and Committee Meetings
Note: Agendas for some sessions will not be posted.
- ACS CRP- Cancer Care Delivery Research
- ACS CRP- Cancer Care Standards Development
- ACS CRP- Dissemination and Implementation
- ACS CRP- Education Committee
- ARM (Axillary Reverse Mapping) Training
- Biorepository Committee
- Breast Committee
- Breast Local Control Group
- Cancer in the Older Adult Committee
- Community Oncology Committee
- CRP Education
- CRP Information
- Experimental Therapeutics Committee
- Genitourinary Committee
- GI Committee
- Health Outcomes Committee
- Immuno-Oncology Working Group
- Leukemia Committee
- Lymphoma Committee
- Methodology Working Group
- Multiple Myeloma Committee
- Neuro-Oncology Committee
- New Investigator Committee
- Pharmacogenetics and Population Pharmacology Committee
- Prevention Committee
- Radiation Oncology Committee
- Respiratory Committee
- Symptom Intervention Committee
- Transplant Committee
AGENDAS: Alliance Foundation Trials (AFT)
Note: Agendas for some sessions will not be posted.
- AFT 15
- AFT 19
- AFT 25 (COMET)
- AFT 28
- AFT 29
- AFT 32
- AFT 38 (PATINA)
- AFT 39
- AFT 41
- AFT 42
PRESENTATIONS: Sessions and Workshops
Audit Workshop
Introduction to Alliance Audit
Alliance Audit Regulatory Review
CRP Information Session
Allliance Statistics and Data Center Updates
Alliance Administrative and Protocol Office Update
CRP/Nursing Open Forum
Utilizing a Central Screening Process to Enhance Accrual at a Community NCORP
CRP Education Session
Alliance Protocol Status Sheet
Implementation of CIRB Requirements
Managing Delegation of Tasks Logs
Lead CRA/Administrator Tips
CRP/Nursing Open Forum
Utilizing a Central Screening Process to Enhance Accrual at a Community NCORP
Boost Your CRP Skills
Note: Presentations for some sessions/workshops will not be posted.
* * * * * * * * * *
2018 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 10-12
SCHEDULE: Day-to-Day Guide
Continuing Education (CE) Credit Sessions and Amounts
New Alliance Meeting App Instructions
AGENDAS: Sessions and Committee Meetings
Note: Agendas for some sessions will not be posted.
- ACS CRP- Cancer Care Delivery Research
- ACS CRP- Cancer Care Standards Development
- ACS CRP- Dissemination and Implementation
- ACS CRP- Education Committee
- Biorepository Committee
- Breast Committee
- Cancer in the Older Adult Committee
- Community Oncology Committee
- CRP Education
- CRP Information
- CRP Orientation
- CRP Reception Flyer
- CRP Reception Map
- Experimental Therapeutics Committee
- GI Committee
- Health Disparities Committee
- Health Disparities Education Session
- Health Outcomes Committee
- Leukemia Committee
- Lymphoma Committee
- New Investigator Course
- Pharmacogenetics and Population Pharmacology Committee
- Prevention Committee
- Radiation Oncology Committee
- Respiratory Committee
- Symptom Intervention Committee
AGENDAS: Alliance Foundation Trials (AFT)
Note: Agendas for some sessions will not be posted.
PRESENTATIONS: Sessions and Workshops
Note: Presentations for some sessions/workshops will not be posted. Please click on the link above to access all the presentations that we've received.
* * * * * * * * * *
2017 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 2-4
Continuing Education (CE) Credit Sessions and Amounts
AGENDAS: Sessions and Committee Meetings
Note: Agendas for some sessions will not be posted.
- ACS CRP- Cancer Care Delivery Research
- ACS CRP- Cancer Care Standards Development
- ACS CRP- Dissemination and Implementation
- ACS CRP- Education Committee
- Audit Workshop
- Breast Committee
- Biorepository Committee
- Cancer in the Elderly Committee
- Community Oncology Committee
- CRP Education
- CRP Information
- CRP Surgery
- Experimental Therapeutics and Rare Tumor Committee
- Gastrointestinal (GI) Committee
- Health Disparities Committee
- Health Outcomes Committee
- Leukemia/Leukemia Correlative Sciences Committee
- Lymphoma Committee
- Methodology Committee
- Multiple Myeloma Committee
- Neuro-Oncology Committee
- Patient Advocate Committee
- Pharmacogenetics and Population Pharmacology Committee
- Prevention Committee
- Radiation Oncology Committee
- Respiratory Committee
- Symptom Intervention Committee
AGENDAS: Alliance Foundation Trials (AFT)
Note: Agendas for some sessions will not be posted.
PRESENTATIONS: Sessions and Workshops
Note: Presentations for some sessions/workshops will not be posted.
-
Audit Workshop
- Welcome and Audit Resources Presenter: Barbara Barrett, MS, CCRP, Audit Program Director
- Introduction to the Alliance Audit Program Presenter: Scott Okuno, MD, Chair of the Alliance Audit Committee, Mayo Clinic
- IRB Documentation and Informed Consent Content Presenter: Kurombi Wade-Oliver, CCRP, Alliance Clinical Trials Auditor
- Patient Case Records Review Presenter: Debra Herzan, RN, OCN, CCRP, Alliance Clinical Trials Auditor
- Review of Accountability of Investigational Agents and Pharmacy Operations Presenter: Rosalyn Williams, Alliance Clinical Trials Auditor
- Responding to Audit Findings and Preparing a Corrective Action Plan Presenter: Barbara Barrett, MS, CCRP, Audit Program Director
-
Breast Committee
- Opportunities for QI Tools in Breast Oncology Presenter: Nola Hylton, PhD, UCSF & Maryellen Giger, PhD, University of Chicago
-
Clinical Research Professional (CRP) Information Session
- Alliance Administrative and Protocol Office Update Presenter: Michael Kelly, MA, Director of Protocol Operations
- Alliance SDC Updates Presenter: Jennifer Darcy, CCRP, Directer, Alliance Statistics and Data Center
- CTSU Updates Presenter: Martha Hering, Project Manager, CTSU/Westat
- Importance of Timely Data Submission Presenter: Shauna Hillman, MS, Alliance Statistician
- NCI Informed Consent Presenter: Grace Mishkin, MPH, National Cancer Institute
-
Clinical Research Professional (CRP) Information Breakout Sessions
- It's All About that Rave Presenter: Ryan Potaracke, Alliance SDC
- RCR Demonstration Presenter: Matthew Boron, PMB, CTEP, National Cancer Institute
- The Role of Patient Advocates in Clinical and Translational Research Presenter: Patty Spears, Co-Chair Alliance Patient Advocates Committee
-
Clinical Research Professional (CRP) Education Session
- CTMB Updates Presenter: Barbara Barrett, MS, CCRP, Audit Program Director
- A021502 Presenter: Frank Sinicrope, MD, Mayo Clinic
- A021502 (ATOMIC) SAE Integration and Central Monitoring Presenters Shauna Hillman, MS, Alliance Statistician & Martha Hering, Project Manager, CTSU/Westat
-
Clinical Research Professional (CRP) Education Breakout Sessions
- ​AFT Monitoring vs Auditing Presenter: Trini Ajazi, MM, Alliance Chief Administrative Officer
- CTSU Reports Presenter: Martha Hering, Project Manager, CTSU/Westat
- DTL Demonstration Presenter: Matthew Boron, PMB, CTEP, National Cancer Institute
-
Clinical Research Professional (CRP) Surgical Workshop
- A011104 Presenter: Isabelle Bedrosian, MD, MD Anderson Cancer Center
- A221208 Presenter: Caroline Chung, MD, MD Anderson Cancer Center
- Alliance Biorepositories and Biospecimen Resource Presenter: Mark Watson, M.D., Ph.D., Director of Alliance Biorepository
-
Imaging Committee
- The Role of the Experimental Therapeutics and Rare Tumor Committee (ETRTC) in Drug Development Presenter: Gary K. Schwartz, MD, Herbert Irving Comprehensive Cancer Center
-
Young Investigators Committee
- How to Work with Your Statistician Presenter: Fang-Shu Ou, PhD, Faculty Statistician, Alliance Statistics and Data Center
PRESENTATIONS: Alliance Foundation Trials (AFT)
Note: Presentations for some sessions/workshops will not be posted.
- AFT 25 (COMET)
* * * * * * * * * *
2017 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 10-13
SCHEDULE: Day-to-Day Guide
AGENDAS: Sessions and Committee Meetings
Check back often for updates and additional agendas. Note that agendas for some sessions will not be posted.
- ACS CRP- Cancer Care Delivery Research
- ACS CRP- Cancer Care Standards Development
- ACS CRP- Dissemination and Implementation
- ACS CRP- Education Committee
- Breast Committee
- Cancer in the Elderly Committee
- Community Oncology Committee
- CRP Education Session
- CRP Information Session
- CRP Orientation
- Experimental Therapeutics and Rare Tumor Committee
- Gastrointestinal (GI) Committee
- Health Disparities Committee
- Health Disparities Education Session
- Health Outcomes Committee
- Neuro-Oncology Committee
- New Investigator Course
- Nursing and CRP Open Forum
- Patient Advocate Committee
- Pharmacogenetics and Population Pharmacology Committee
- Prevention Committee
- Radiation Oncology Committee
- Respiratory Committee
- Symptom Intervention Committee
PRESENTATIONS: Sessions and Workshops
Check back often for updates and additional presentations. Note that presentations for some sessions/workshops will not be posted.
-
Charles G. Moertel Lecture | Plenary Session
- SOFTly: The Long Natural History of [Trials for] [Premenopausal] ER+ Breast Cancer Presenter: Gini F. Fleming, MD, Director and Principal Investigator, Alliance Central Protocol Operations Program
-
Clinical Research Professional (CRP) Orientation
- Alliance Organizational Structure Presenter: Trini Ajazi, MM, Alliance Chief Administrative Officer
- BioSpecimen Management System Presenter: Amy Brink, Washington University School of Medicine
- Data Management Presenter: Kristin Honer, Essentia Health
- Eligibility Presenter: Jennifer Dill, CCRP, Washington University School of Medicine
- Navigating Alliance Protocols Presenter: Morgen Alexander-Young, MPH, Alliance Central Protocol Operations Program
- RECIST Presenter: Scott Okuno, MD, Audit Committee Chair
-
Clinical Research Professional (CRP) Information Session
- Alliance Administrative & Protocol Office Update, Trini Ajazi, MM, Alliance Chief Administrative Officer
- CTSU Updates Presenter: Kathi Celii, Project Manager, CTSU
- Alliance Statistics and Data Center Updates Presenter: Jenny Darcy, CCRP, Directer, Alliance Statistics and Data Center
- FDA Inspection Overview Presenters: Aimee Farrell, Alliance Senior Project Manager & Jennifer Gaskin, Alliance Director of Quality and Compliance
- NCI: Registration and Credential Repository (RCR) & Delegation of Tasks Log (DTL) Presenter: Donna Shriner, RPh, Pharm D, MPH, Senior Clinical Research Pharmacist
-
Clinical Research Professional (CRP) Information Breakout Sessions
- CTSU Projects and Integration Presenter: Kathi Celii, Project Manager, CTSU
- Making the Job Your Own: Protocol Compliance Workshop Presenters: Tammie Mlodozyniec, CCRP, Essientia Health & Amy Van Hecke, CCRP, Essientia Health
- Nursing/CRP Diease Site Presentation: Sarcoma Presenter: Scott Okuno, MD, Audit Committee Chair
-
Clinical Research Professional (CRP) Education Session
- A011502 Presenter: Wendy Chen, MD, MPH, Harvard University
- Physician Engagement Presenter: Bret Friday, MD, PhD, Essientia Health
-
Clinical Research Professional (CRP) Education Breakout Sessions
- It's All Grays to Me: Understanding Radiation Data Presenter: Hiram Gay, MD, Washington University School of Medicine
- A051301 Presenter: Babis Andreadis, MD, MSCE, USCF
-
Health Disparities Education Session | Catchment Areas: Engaging our Communities for Improved Outcomes
- Definition of Catchment Areas Presenter: Electra D. Paskett, PhD, Ohio State University Comprehensive Cancer Center
- How to Identify Community Partners & Develop Linkages to Enhance Recruitment Presenter: Deborah Erwin, PhD, Roswell Park Cancer Institute
- Real Life Example: Nueva Vida Intervention Presenters: Kristi Graves, PhD, Georgetown University School of Medicine and Ivis Sampayo, Alliance Patient Advocate
-
New Investigator Course
- NCTN Presenter: Grace Mishkin, MPH, NCTN Operations
- NCORP Presenter: Worta McCaskill-Stevens, M.D., MS, NCORP Director
- IROC Presenter: Fran Laurie, BS, Director of Operations, IROC Rhode Island
- PCORI Presenter: Sarah Daugherty, Ph.D., MPH, Senior Program Officer, Clinical Effectiveness and Decision Science
- CCDR Presenter: Stephen B. Edge, M.D., FACS, FASCO, Vice President, Healthcare Outcomes and Policy
- E-PROS Presenter: Lori Minasian, MD, FACP, Deputy Director, Division of Cancer Prevention
- Introduction to AFT Presenter: Suzanne George, M.D., Alliance Vice Group Chair
- Alliance Patient Advocates Presenters: Pat Gavin, RPh, Co-Chair Alliance Patient Advocate Committee & Patty Spears, Co-Chair Alliance Patient Advocate Committee
- RSS/OPEN/credentialing, cIRB, OEWG Presenter: Michael Kelly, MA, Alliance Director of Protocol Operations
- Medicare funding sheets, SOC cost issues & working with your EO Presenter: Olwen Hahn, M.D., Former Alliance Executive Officer
- IND, IDE, International Trials, Registration Trials, & COI Presenter: Trini Ajazi, MM, Alliance Chief Administrative Officer
- Working with your Statistician Presenter: Jennifer Le-Rademacher, PhD, Faculty Statistician, Alliance Statistics and Data Center
- Forms Development and RAVE Presenter: Shauna Hillman, MS, Statistician
- Biospecimens and Biobanking Presenter: Mark Watson, M.D., Ph.D., Director of Alliance Biorepository
- Contracts Presenter: Angela Klein, Alliance Director of Contracts Management
- Clinical Trial Design Presenter: Fang-Shu Ou, PhD, Faculty Statistician, Alliance Statistics and Data Center
- Study Budget Presenters: Bobby S. Bangura, MBA, Clinical Study Budget Analyst, Alliance Foundation Trials, LLC & Denise Collins-Brennan, Director and Financial Chief Officer, Alliance for Clinical Trials in Oncology
- Incorporating Translational Science Presenter Fraser Symmons, M.D., Professor of Pathology, MD Anderson Cancer Center
- Community Oncology Matters Presenters: Daniel M. Anderson, MD, MPH, Metro-MN Community Oncology Research Consortium, Jon Strasser, MD, Delaware/Christiana Care & Peggy Kemeny, MD, Queens Hospital Center
PRESENTATIONS: Alliance Foundation Trials (AFT)
Check back often for updates and additional presentations. Note that presentations for some sessions/workshops will not be posted.
- AFT-28 CANVAS
* * * * * * * * * *
2016 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 2-5
SCHEDULE: Day-to-Day Guide
AGENDAS: Sessions and Committee Meetings
Check back often for udpates and additional agendas. Note that agendas for some sessions will not be posted.
- Alliance/American College of Surgeons Clinical Research Professional Program (ACS CRP) - Cancer Care Delivery Research Committee
- ACS CRP - Cancer Care Standards Development
- ACS CRP - Dissemination and Implementation Committee
- ACS CRP - Education Committee
- ACS CRP - Executive Committee
- Audit Workshop
- Breast Cancer Surgery
- Cancer Control Program (CCP) - Cancer in the Elderly Committee
- CCP - Community Oncology Committee
- CCP - Health Disparities Committee
- CCP - Health Outcomes Committee and QoL Methodology
- CCP - Prevention Committee
- CCP - Symptom Intervention Committee
- Clinical Research Professionals (CRP) Education Session
- CRP Information Session
- CRP Orientation Session
- Gastrointestinal (GI) Committee
- Leukemia/Leukemia Correlative Sciences Committee
- Lymphoma Committee
- Patient Advocate Committee
- Radation Oncology Committee
- Respiratory Committee
- Surgical CRP Workshop
- Translational Research Program - Pharmacogenomics and Population Pharmacology Committee
PRESENTATIONS: Sessions and Workshops
Check back often for udpates and additional presentations. Note that presentations for some sessions/workshops will not be posted.
-
Audit Workshop
Welcome to Audit Workshop
Preparing Your Audit Response: Corrective and Preventative Action Plans (CAPAs)
Presenter: Barbara Barrett, MS, CCRP, Alliance Audit Program Director
Patient Case Records Review
Presenter: Debra Herzan, RN, OCN, CCRP, Alliance Clinical Trials Auditor
Introduction to Alliance Audit
Presenter: Scott Okuno, MD, Audit Committee Chair
Alliance Audit Regulatory Review
Presenter: Kurombi Wade-Oliver, CCRP, Alliance Clinical Trials Auditor
Audit Pharmacy Review
Presenter: Rosalyn D. Williams, Alliance Clinical Trials Auditor -
New Clinical Research Professional (CRP) Orientation
RECIST
Presenter: Scott Okuno, MD, Audit Committee Chair
Informed Consent
Presenter: Jim Luecht, CCRP, Inova Schar Cancer Institute, Fairfax VA
Data Management: Helpful Tips & Common Errors
Presenter: Kristin Honer, Essentia Health
Understanding AE Reporting
Presenter: Peg Reamer, RN, BSN,University of Pittsburgh Department of Cardiothoracic Surgery
Checking Eligibility: Keys To Successful Patient Enrollment
Presenter: Katie Dixon
Navigating Alliance Protocols: Where to Find it and Whom to Contact
Presenter: Michael Kelly, MA, Director of Protocol Operations
Alliance Central Protocol Operations Program Update
Presenter: Michael Kelly, MA, Director of Protocol Operations -
Clinical Research Professional (CRP) Information Session
Data Management Updates
Presenter: Jenny Darcy, Alliance Statistics and Data Center
Clinical Trials Support Unit
Presenter: Lucille Patrichuk, BSN, MBA
Your Feedback on Study Result Summaries
Presenter: Deborah Collyar, Publications Committee
BioSpecimen Management System-BioMS
Presenter: Amy Brink, Senior Research Tech, Washington University School of Medicine
Where We Are: NCI’s Informed Consent Template and Updates to Address Changing Needs
Presenter: Andrea M. Denicoff, MS, RN, Cancer Therapy Evaluation Program,Division of Cancer Treatment & Diagnosis -
Clinical Research Professional (CRP) Information Breakout Sessions
Overview of Breast Cancer
Presenter: Gary W. Unzeitig, MD, FACS -
Clinical Research Professional (CRP) Education Session
It All Starts Here: Obtaining Informed Consent in the Real World
Presenters: Betsy Barnick, MHSc, CCRP, Carle Foundation Hospital, Urbana IL and Jim Luecht, CCRP, Inova Schar Cancer Institute, Fairfax VA -
Clinical Research Professional (CRP) Education Breakout Sessions
MCA Integration into Alliance Clinical Trials
Presenter: Lisa R. Pitler, JD, MS, RN, University of Illinois at Chicago
Hematology Malignancies
Geoffrey L. Uy, MD, Washington University School of Medicine
Alliance A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss In Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Presenter: Jennifer Ligibel, MD -
Clinical Research Professional (CRP) Surgery Breakout Sessions
Alliance A211401- Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Presenters: Ivana T. Croghan, PhD and Jeff Sloan, PhD
Alliance A021501 - Preoperative Chemotherapy and Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Presenter: Matthew Katz, MD, FACS
PROSPECT: Preoperative Radiation or Selective Preoperative Radiation and Evaluation Before Chemotherapy and TME
Presenter: Deborah Schrag, MD, MPH, Dana-Farber Cancer Institute -
Oncology Nursing Education Sessions
Immunotherapy, An Exciting Era!!
Presenter: Yousef Zakharia MD, University of Iowa and Holden Comprehensive Cancer Center
Managing Immunotherapy Toxicity: The Good, the Bad, and the Ugly
Presenter: Lisa A. Kottschade APRN, MSN, CNP, Mayo Clinic-Rochester, MN -
Young Investigators Committee
Brief Study Chair Guidelines
Presenter: Gini Fleming, MD
* * * * * * * * * *
2016 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 12-14
SCHEDULE: Day-to-Day Guide
Open Session Teleconference Phone Lines
AGENDAS: Sessions and Committee Meetings
Check back often for udpates and additional agendas. Note that agendas for some sessions will not be posted.
- ACS CRP Cancer Care Delivery Research Committee
- ACS CRP Cancer Cancer Standards Development Committee
- ACS CRP Education Committee
- ACS CRP Executive Committee
- Cancer in the Elderly Committee
- Community Oncology Committee
- Clinical Research Professionals (CRP) Education Session
- Clinical Research Professionals (CRP) Information Session
- Experimental Therapeutics Committee
- Gastrointestinal (GI) Committee
- Health Disparities Committee
- Health Outcomes Committee
- Leukemia / Leukemia Correlative Science Committees
- Lymphoma Committee
- Neuro-Oncology Committee
- Oncology Nursing (A-ONC) Education Session
- Pathology Committee
- Patient Advocate Committee (PAC)
- Prevention Committee
- Radiation Oncology Committee
- Symptom Intervention Committee
- Transplant Committee
PRESENTATIONS: Sessions and Workshops
Check back often for udpates and additional presentations. Note that presentations for some sessions/workshops will not be posted.
-
Cancer in the Elderly Committee (Cancer Control Program)
Accrual of Older Breast Cancer Parents to Alliance Systemic Therapy Trials Over Time: Protocol A15127
Presenter: Rachel Freedman, MD, MPH (Dana-Farber Cancer Institute)
The Impact of Full Body Weight-Based Chemotherapy Dosing on Adverse Events and Outcome in Older Breast Cancer Patients: Results from Cancer and Leukemia Group B (CALGB) Trial 49907
Presenter: Vicki A. Morrison, MD (University of Minnesota)
Feasibility of an Electronic Geriatric Assessment (eGA) for Older Adults with Cancer
Study Group: Emily Guerard, MD; Ryan Nipp, MD; Grant Williams, MD; Armin Shahrokni, MD; Jeff Sloan, PhD; Travis Dockter, MS; Arti Hurria, MD; Aminah Jatoi, MD; Harvey Cohen, MD; Hyman Muss, MD
Identifying Risk Factors For Toxicity in Patients With Hormone Receptor Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study
Presenter: Daneng Li, MD (City of Hope)
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Study Team: George J Chang, MD, MS (MD Anderson Cancer Center); Daniel Dohan, PhD (University of California, San Francisco); Amylou Dueck, PhD (Mayo Clinic); Emily Finlayson, MD, MS (University of California, San Francisco); Lisa Lowenstein, PhD, MPH, RD (MD Anderson Cancer Center); Supriya Mohile, MD, MS (University of Rochester)
Malignant Hematologic Complications Among Older Patients Receiving Adjuvant Anthracycline-Based Chemotherapy on Modern Cooperative Group Trials
Presenter: Rachel Freedman, MD, MPH (Dana-Farber Cancer Institute)
Musculoskeletal Events in Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer (Alliance A171302)
Study Team: Judith O. Hopkins; Jake Allred; Arti Hurria; Aminah Jatoi; Jacqueline M. Lafky; Harvey Cohen; Cliff Hudis; Eric Winer; Jeanne Mendleblatt; Hyman B. Muss
Pooled Survival Analysis of First-line Carboplatin Doublet Chemotherapy for Advanced Non-small Cell Lung Cancer in Elderly Patients vs. Younger Patients Enrolled in CALGB Trials
Presenters: Josephine Feliciano; Jared Foster; Ajeet Garja; Aminah Jatoi
Update on Acute Myeloid Leukemia (AML) Trials in Older Adults
Presenter: Heidi D. Klepin, MD, MS (Wake Forest School of Medicine) -
Clinical Research Professionals (CRP) Education Session
Pharmacy and Oral Pill Compliance
Oral Pill Compliance and Source Documentation
Presenters: Barbara Barrett, MS, CCRP (Alliance Audit Program Director) and Brenda Gebhart, RPh (Investigational Pharmacist)
You Have a Study Ready to Open, Now What?
Presenter: Peg Reamer, RN, BSN -
Clinical Research Professionals (CRP) Information Session
Site Study Start-Up Requirements for AFT Studies
Presenter: Alicia Quirke (Site Manager)
Where We Are: NCI’s Informed Consent Template and Updates to Address Changing Needs
Andrea M. Denicoff, MS, RN, Cancer Therapy Evaluation Program, Division of Cancer Treatment & Diagnosis -
Clinical Research Professionals (CRP) Learning Sessions
CRP Administrator: IPEC Reports
Presenter, Marcia Kelly (Alliance Membership Manager)
CRP Administrator/Study Coordinator: Prepping Pharmacy for Audit (Revised)
What Can You Do Now to Prepare for Pharmacy Audits?
Presenters: Barbara Barrett, MS, CCRP (Alliance Audit Program Director) and Brenda Gebhart, RPh (Investigational Pharmacist)
CRP Data Manager: Meet Your Data Manager
Presenters: Jenny Darcy (Associate Director, Alliance Data Coordination Unit); Julie Moriarity (IT Liaison/Alliance Service Center); Chelsea Schultz (IT Liaison/Alliance Service Center) and Tiffany Schafer (Alliance Data Manager Supervisor)
CRP Specimen Submission: BioMS Training and Update 2.0
Presenters: Amy Brink and Mark Watson, Washington University School of Medicine
CRP Study Coordinator: A01123 (Breast) Study Training
Presenter: Matthew P. Goetz, MD
CRP Study Coordinator: A221405 (Breast) Study Training
CRP Study Coordinator: A221405 (Breast) Study Training (Shortened Version)
Presenter: Ann H. Partridge, MD, MPH (Dana-Farber Cancer Institue)
CRP Study Coordinator: A031102 (GU) Study Training
Presenter: Darren R. Feldman, MD (Memorial Sloan Kettering Cancer Center) -
Community Oncology Committee (Cancer Control Program)
A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Presenters: Ivana T. Croghan, PhD and Jeff Sloan, PhD
A Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients with High Grade Glioma
Presenter: Alyx Porter, MD
A Randomized Double-Blind Placebo Controlled, Phase II/III, Study of Aromatase Inhibitors and Transdermal Testosterone in the Adjuvant Treatment of Postmenopausal Women with Aromatase Inhibitor Induced Arthralgias: A221102
Presenters: Stephen Birrell, MD, PhD and Charles Loprinzi, MD
Alliance A221208: Phase II Randomized Study of Bevacizumab vs. Steroids (BeSt) for Radionecrosis After Radiosurgery for Brain Mets
Study Co-Chairs: Caroline Chung and Warren Mason
CALGB 30901: Randomized Phase II Study of Maintenance Pemetrexed vs. Observation for Patients with Malignant Mesothelioma Without Progression After First-Line Chemotherapy
Presenter: Arkadiusz Dudek, MD, PhD, FACP
CCDR Committee Updates
Presenter: George J Chang, MD MS
Decision Aids for Prostate Cancer in Minority Men: A191402
Presenter: Jon Tilburt, MD (Mayo Clinic)
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Study Team: George J Chang, MD, MS (MD Anderson Cancer Center); Daniel Dohan, PhD (University of California, San Francisco); Amylou Dueck, PhD (Mayo Clinic); Emily Finlayson, MD, MS (University of California, San Francisco); Lisa Lowenstein, PhD, MPH, RD (MD Anderson Cancer
Center); Supriya Mohile, MD, MS (University of Rochester)
Mentoring and Development of Young Community Investigators and Research Leaders for the Future
Presenters: James Bearden, MD and Amy Curtis, MD
NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131): Interim Analysis Results
Study Chairs: Keith T. Flaherty; Alice P. Chen; Peter J. O'Dwyer; Barbara A. Conley; Stanley R. Hamilton; Mickey Williams; Robert J. Gray; Shuli Li; Lisa M. McShane; Lawrence V. Rubinstein; Susanna I. Lee; Frank I. Lin; Paolo F. Caimi; Albert A. Nemcek, Jr.; Edith P. Mitchell; James A. Zwiebel -
Health Disparities Committee (Cancer Control Program)
Decision Aids for Prostate Cancer in Minority Men: A191402
Presenter: Jon Tilburt, MD (Mayo Clinic)
Establishing a Cohort of African-American Men to Validate a Method for using Serial PSA Measures to Detect Aggressive Prostate Cancers
Presenters: James R. Hebert, ScD (University of South Carolina) and Azza Shoaibi, PhD (Medical University of South Carolina)
Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG / CALGB / NCCTG Trials
Presenter: Mary Beth Terry, PhD (Mailman School of Public Health)
Increasing Patient Engagement in Breast Cancer Surgery Decision Making
Presenter: Heather B. Neuman, MD, MS (University of Wisconsin School of Medicine and Public Health)
Risk Modeling for Breast-Specific Outcomes, CVD Risk, and Overall Mortality in Alliance Clinical Trials of Breast Cancer
Presenter: Mary Beth Terry, PhD (Mailman School of Public Health)
UIC P20–Pilot Research Project Core | Roswell Park Cancer Institute Disparities Updates -
Health Outcomes Committee (Cancer Control Program)
A201501 Phase II Dignity Therapy / Life Plan in Patients with Pancreatic or Advanced Lung Cancer: Lessons Learned from Concept Submission
Presenter: Ann Marie Dose, PhD, RN, ACNS-BC, ACHPN (Mayo Clinic)
A221504: A Randomized, Double-blind, Placebo-controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-small Cell Lung Cancer (Adenocarcinoma)
Presenter: Pankaj Gupta, MD (Minneapolis VA Health Care System)
CCDR Committee Updates
Presenter: George J Chang, MD MS
Economic Evaluation Service | Kern Center for Science of Healthcare Delivery Mayo Clinic
Presenter: Bijan J. Borah, PhD (Mayo Clinic College of Medicine)
Decision Making and Communication about Contralateral Prophylactic Mastectomy
Presenter: Clara Lee, MD, MPP, FACS (University of North Carolina)
A Novel Approach to Analyzing Toxicity in Lymphoma Clinical Trials
Presenter: Gita Thanarajasingam, MD (Mayo Clinic)
A211401: Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes
Presenters: Ivana T. Croghan, PhD and Jeff Sloan, PhD -
Oncology Nursing (A-ONC) Education
Chimeric Antigen Receptor T Cell Therapy / CART
Presenter: Yi Lin, MD, PhD (Mayo Clinic) -
Prevention Committee (Cancer Control Program)
Data Harmonization & Preliminary Analysis for a Pooling Project of 7 Completed Alliance Trials
Presenter: Erica Peters, PhD (Battelle Public Health Center for Tobacco Research)
Optum Labs Overview
Presenter: Bijan J. Borah, PhD (Mayo Clinic College of Medicine)
* * * * * * * * * *
2015 FALL GROUP MEETING PRESENTATIONS & MATERIALS / November 5-8
AGENDAS: Sessions and Committee Meetings
Check back often for udpates and additional agendas. Note that agendas for some sessions will not be posted.
- ACS CRP Cancer Care Delivery Research (CCDR) Committee
- ACS CRP Dissemination and Implementation Committee
- ACS CRP Education Committee
- ACS CRP Executive Committee
- Audit Committee
- Breast Committee
- Breast Surgery Meeting
- Cancer in the Elderly Committee
-
Community Oncology Committee
Download Important Information About CRP Breakout Sessions (pdf)
CRP Teleconference Lines (pdf)
Also note that CRP Information and Education Breakout Sessions are only available for CE credits if they are attended in person. Unfortunately, sessions attended via webinar are not available for CE credit. - Clinical Research Professionals (CRP) Breakout Session #1
- Clinical Research Professionals (CRP) Breakout Session #2
- Clinical Research Professionals (CRP) Education Session
- Clinical Research Professionals (CRP) Information Session
- Clinical Research Professional (CRP) Surgery Agenda
- Experimental Therapeutics Committee
- Gastrointestinal (GI) Committee
- Genitourinary (GU) Committee
- Health Disparities Committee
- Health Outcomes Committee
- Leukemia/Leukemia Correlative Sciences Committee
- Lymphoma Committee
-
Neuro-Oncology Committee
Alliance Immunotherapy in Neuro-Oncology / Discussion of A071101
Neuro-Oncology Imaging SubCommittee - Oncology Nursing Education Session
- Patient Advocate Committee (PAC)
- Pharmacogenomics and Population Pharmacology (PPP) Committee
- Prevention Committee
- Radiation Oncology Committee
- Respiratory Committee
- Symptom Intervention Committee
PRESENTATIONS: Sessions and Workshops
-
Audit Preparation
Audit Pharmacy Review
Audit Preparation | Introduction to Alliance Audit
Audit Preparation | Opening Slides
Audit Preparation | Patient Case Records Review
Audit Regulatory Review
Preparing Your Audit Repsonse - Corrective and Preventative Action Plans (CAPAS) -
CRP Breakout
Making the Job Your Own
Navigating Multi-Disciplinary Protocols at the Site Level
Logistics of ALCHEMIST Screening Trial
Using NCI CIRB
Alliance A11104 - ACRIN 6694 Effect of Preoperative Breast MRI
Navigating Studies Under CIRB
It's All the Rave
Alliance A041202 Study Review
Building Relationships with Your Investigators
CTSU Presentation
It's Gray to Me
NCTN-NCORP Funding Info for Sites
IROC Imaging & Radiation Oncology (updated)
NCTN-NCORP Navigating Site Codes-MD Registrations -
CRP Information
CRP Committee As-A-Resource
Alliance SDC Updates -
CRP Surgery
Reducing Surgical Complication In Newly Diagnosed Lung Cancer Patients Who Smoke
-
Health Disparities
Overtesting Pros and Cons From Patient Perspective (updated)
Overtesting in Cancer Staging
Patient Perspective on Overtesting -
Oncology Nursing
Alliance Brain Tumor Trials 101: Everything You Wanted to Know and More
Therapeutic Resistance to Temozolomide and Temozolomide Sensitizing Strategies
* * * * * * * * * *
2015 SPRING GROUP MEETING PRESENTATIONS & MATERIALS / May 13-16
AGENDAS: Sessions and Committee Meetings (Note: Agendas will be added as received from committee chairs; agendas for some sessions will not be posted.)
- ACS CRP Cancer Care Delivery Research (CCDR) Committee
- ACS CRP Cancer Care Standards Development (CCSD) Committee
- ACS CRP Education Committee
- Cancer in the Elderly Committee
- CCP Health Disparities Committee
- CCP Health Outcomes Committee
- CCP Prevention Committee
- CCP Symptom Intervention Committee
- Community Oncology Committee
- Clinical Research Professionals (CRP) Education Session
- Clinical Research Professionals (CRP) Information Session
- Experimental Therapeutics Committee
- Gastrointestinal (GI) Committee
- Genitourinary (GU) Committee
- Neuro-Oncology Committee
- Oncology Nursing Education Session
- Patient Advocate Committee
- Pharmacogenomics and Population Pharmacology Committee
- Radiation Oncology Committee
- Respiratory Committee
- Transplant Committee
PRESENTATIONS: Sessions and Workshops
-
CRP Education
ALCHEMIST
Building Relationships with your Investigators
CALGB 10403
Medidata Rave
RECIST Overview
Staging Restaging and Response Eval in Lymphomas
-
CRP Information
CTSU Updates
Medicare Billing
NCI CIRB
Pearls of Wisdom Intro
Pearls of Wisdom Patient Case Review
Pearls of Wisdom Pharmacy
Pearls of Wisdom IRB ICC Review
Strategies for ALCHEMIST Implementation
Pearls of Wisdom IRB Review
A031201 Training
CTSU Website-OPEN
* * * * * * * * * *
2014 Fall Group Meeting Presentations & Materials / November 5-8
Alliance Published Manuscripts
AGENDAS: Sessions and Committee Meetings (Please note: Agendas will be added as they're received from committee chairs; agendas for some sessions will not be posted.)
- Audit Preparation Workshop
- ACS CRP Cancer Care Delivery Research (CCDR)
- ACS CRP Education Session
- ACS CRP Plenary Session
- Breast Committee
- Cancer Control Program (CCP) Executive Committee
- Cancer in the Elderly Committee
- Clinical Research Professionals Education Session
- Clinical Research Professionals Information Session
- Community Oncology Committee
- Experimental Therapeutics Committee
- Gastrointestinal (GI) Committee
- Genitourinary (GU) Committee
- Health Disparities Committee
- Health Outcomes Committee
- Leukemia/Leukemia Correlative Sciences Committee
- Lymphoma Committee
- Neuro-Oncology Committee
- Patient Advocate Committee
- Pathology Committee
- Pharmacogenomics and Population Pharmacology (PPP) Committee
- Pharmacy Committee
- Prevention Committee
- Respiratory Committee
- Surgical Clinical Research Professionals Workshop
- Symptom Intervention Committee
PRESENTATIONS: Sessions and Workshops
-
Audit Preparation Workshop (CE Credit)
Opening Slides
Alliance Audit Program
Audit Findings and CAPA
Drug Accountability and Pharmacy Operations
IRB Documentation
Patient Case Review
PI Perspective -
CRP Education (CE Credit)
Alliance A071101
CT AIM MATRIX TOOL
Substrate Binding by DnaK
SWOG S1400 -
CRP Information (CE Credit)
ALCHEMIST Update
CTSU
Medidate Rave Update
NCI CIRB
What is Quality in Research?
Alliance A11104/ACRIN 6694: Effect of Preoperative Breast MRI onSurgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
Consolidation of Legacy CALGB Data Management Services to Mayo (non-CE) -
CRP Surgery Workshop Alliance A21102 (CE Credit)
ALCHEMIST Specimen Submission Logistics (non-CE)
CRP Surgery Workshop Evaluation Form - Experimental Therapeutics Committee Presentation
-
14th Annual Jimmie Holland Lecture Series (CE Credit)
Presented by the Alliance Cancer Control Program -
The Importance of Race in Clinical Trials (CE Credit)
Presented by the Alliance Health Disparities Committee Education & Training Working Group
Comparison of Baseline QOL Between Minorities and Non Minority Patients Jeff A. Sloan, MD
Inclusion of Women Minorities and Children Judith S. Kaur, MD
Oncology Clinical Research and Race-Statistical Principiles Daniel J. Sargent, PhD -
Oncology Nursing Education Session (CE Credit)
The Geriatric Oncology Clinic: Similarities and Differences to a Comprehensive Oncology Clinic -
Translational Research Symposium
Symposium Agenda
Meaningful Biomarkers in Neoadjuvant Trials Federico Innocenti, MD
Neoadjuvant Trial of Molecular Therapy for Melanoma Merrick Ross, MD
Pathologic Response in GI Cancers Jeannelyn S. Estrella, MD
Pathologic Response in Breast Cancers W. Fraser Symmans, MD
Perceived Opportunities and Challenges for Neoadjuvant Trials in GI Cancers Alan Venook, MD
* * * * * * * * * *
2014 Spring Group Meeting presentations & Materials / May 7-10
AGENDAS: Sessions and Committee Meetings
- ACS CRP Cancer Care Delivery Research (CCDR)
- ACS CRP Cancer Care Standards Development (CCSD)
- Breast Surgery Group
- Cancer in the Elderly Committee
- Clinical Research Professionals Education Session
- Clinical Research Professionals Informational Session
- Community Oncology Committee
- Experimental Therapeutics Committee
- Gastrointestinal (GI) Committee
- Genitourinary (GU) Committee
- Health Disparities Committee
- Health Outcomes Committee
- Leukemia Committee
- Lymphoma Committee
- Myeloma Commitee
- Neuro-Oncology Committee
- Oncology Nursing Committee
- Patient Advocate Committee
- Pharmacogenomics and Population Pharmacology (PPP) Committee
- Prevention Committee
- Publications Committee
- Radiation Oncology Committee
- Symptom Intervention Committee
PRESENTATIONS: Sessions and Workshops
-
CRP Education (CE Credit)
- Opening Slides for Session
- Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study (A011106)
- CALGB 30610: Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
- CALGB 40903: Phase II Single-Arm Study of Neoadjuvant letrozole for ER(+) Postmenopausal DCIS
- CRP Information (CE Credit)
- Experimental Therapeutics
- Oncology Nursing (CE Credit)
- Non-CE Credit
